2025年非奈利酮正版的价格是多少？

Finelidone is an important drug for the treatment of chronic kidney disease related to type 2 diabetes. Its genuine price varies depending on factors such as version, specification, and purchase channel. This article will introduce in detail the genuine price of fenelidone in 2025, as well as preparations for the medication of fenelidone and precautions for use in special groups.

What is the genuine price of Fenelidone in 2025?

The specification of the version exported to Japan by Germany's Bayer is 10mg*100 tablets per box, and the price per box is about US$180. The specification of the generic version of Fenelidone by Lucius Laos is 10mg*30 tablets per box, and the price per box is about US$19.

The original drug of Fenelidone has been launched in China and has been included in medical insurance. The winning price of medical insurance is about US$28. The price after reimbursement will be lower and needs to be calculated according to the reimbursement ratio of each region.

These prices are for reference only. The actual purchase of fenelidone may vary due to factors such as region, sales channels, exchange rate fluctuations, etc.

Reasons for the price difference

The reasons for the difference in the genuine price of Fenelidone mainly include production costs, regional differences, sales channels, etc. There are differences in the raw materials, production processes and technical levels used by different manufacturers in the production process, which leads to differences in production costs.

In addition, factors such as market competition, consumption levels, and policy environments in different regions will also affect drug pricing. Different sales channels will also lead to price differences. For example, prices purchased through hospitals, pharmacies, or cross-border e-commerce platforms may be different.

Price Trends and Impact

In recent years, with the continuous development and intensified competition of the global pharmaceutical market, the price of fenelidone has also shown a certain fluctuation trend. As more generic drugs become available and production costs decrease, the price of fenelidone gradually decreases, helping to increase drug accessibility.

Preparation for taking Fenelidone

Before using Fenelidone, patients need to make adequate preparation for taking the drug. Patients should inform their doctors of their detailed medical history and medication use so that the doctor can evaluate the patient's condition and develop an appropriate treatment plan.

Patients need to undergo relevant laboratory tests, such as measuring blood potassium levels and estimating glomerular filtration rate (eGFR). If potassium levels are too high or eGFR is too low, patients may not be candidates for fenelidone. In addition, patients should also understand the medication methods and precautions of fenelidone, such as dosage, medication time, drug interactions, etc.

Importance of laboratory tests

Laboratory tests are crucial before using fenelidone. Serum potassium levels and eGFR are important indicators to evaluate whether a patient is suitable for fenelidone. Hyperkalemia is one of the common adverse reactions during fenelidone treatment, so it is necessary to ensure that the patient's blood potassium level is within a safe range before use. At the same time, the assessment of eGFR helps doctors determine the patient's renal function status and formulate appropriate medication plans.

The necessity of medication guidance

Doctors should provide detailed medication guidance to patients before using fenelidone. This includes information on dosage, duration of medication, drug interactions, and more. Patients should use the medicine correctly according to the doctor's instructions and pay attention to the occurrence of adverse reactions. If there are any discomforts or questions, patients should consult their doctor promptly and adjust their medication plan.

Fenelidone use in special populations

Special attention needs to be paid to the use of fenelidone in special populations. When using fenelidone, doctors should fully evaluate the patient's physical condition and medication risks to ensure the safety and effectiveness of the medication.

Risk assessment for special populations

Special populations are at higher risk when using fenelidone, and the use of fenelidone by pregnant and lactating women may cause adverse effects on the fetus or infant. The safety and effectiveness of fenelidone in children and adolescents have not been established.

In addition, the use of fenelidone in patients with hepatic insufficiency may increase the burden on the liver and lead to serious adverse reactions. Therefore, before using fenelidone, doctors should conduct a comprehensive risk assessment for special groups and formulate corresponding medication plans.

Reasonableness of dose adjustment

For special groups such as patients with liver dysfunction and elderly patients, doctors may need to adjust the dose according to specific circumstances to ensure the safety and effectiveness of the medication. Dosage adjustment should be comprehensively considered based on the patient's physical condition and medication risks, and performed under the guidance of a physician. Patients should not adjust dosage or discontinue medication on their own to avoid unnecessary risks.